Preclinical Stem Cell Models (CNS) Dr. Udo Kraushaar Group Leader Electrophysiology +49 7121 51530-851 E-Mail anzeigen Human stem cells for drug development Stem cell technologies such as induced plur

Compliance at the NMI NMI Sustainability Policy for Suppliers The basis of actions at the NMI are the fundamental principles listed in the United Nations Global Compact. To promote the implementation

Neuronal plasticity within the basolateral amygdala (BLA) is fundamental for fear learning. Metaplasticity, the regulation of plasticity states, has emerged as a key mechanism mediating the subsequent

Young researchers in Reutlingen: A group of students from Albstadt-Sigmaringen University spent the last three days at the NMI and gained an insight into the work of the researchers. Young researchers

At the NMI, the focus is on research work on the production, fragmentation, sterilization and modification of electrospun bulk, hollow and core-sheath fibres for integration into bioinks for the produ

Researchers led by Dr. Michael Pawlak from NMI TT GmbH and Prof. Dr. Hans Neubauer from the Women's Clinic at the University of Düsseldorf have developed a new method that enables a more precise analy

History Foundation and development of the NMI The state needs more application orientation The impetus for founding the NMI came in 1983 from Dr. Günter Hoff, head of research in the "New Technologies

Pharma & Biotech Biomedicine & Materials Science Projects Media Library Jobs NMI achieving results Pioneering research and high-quality services at the interface of medicine, natural sciences and engi

“Leveraging innovative Research Tools to meet public Health Challenges – EU BioMed21 Workshop Perspectives“ The biomedical research landscape is undergoing a transformative shift toward human-centric,

Data privacy Data protection We are pleased about your visit to our website. In the following, we will inform you about which personal data we collect and what happens to this data when you visit our